The Dow Jones index took a slight dip of approximately 10 points on Monday. When insiders engage in buying or selling shares, it offers an insight into their sentiment surrounding the company’s future. For those eyeing penny stocks, this can be a valuable aspect to consider in their investment strategy.
Let’s delve into a few recent significant insider transactions involving penny stocks. For more insights, explore Benzinga’s insider transactions platform.
Insider Buying at Citizens, Inc.
- The Deal: Citizens, Inc. CIA Director Terry Sam Maness picked up 1,000 shares at an average price of $2.14, totaling around $2,137.
- Company Update: On March 18, Citizens announced Jon Stenberg as the new President of the company.
- About Citizens: Citizens Inc. functions as an insurance holding company catering to the life insurance requirements of individuals in the United States.
Insider Activity at Tecogen Inc.
- The Trade: Tecogen Inc. TGEN Director John Hatsopoulos acquired 1,000 shares at an average price of $0.70, amounting to $700.
- Recent Development: On March 13, Tecogen reported revenues of $5.9 million and a net loss of $1.8 million for the quarter ending Dec. 31, 2023.
- About Tecogen: Tecogen Inc. specializes in designing, manufacturing, marketing, and maintaining high-efficiency, ultra-clean cogeneration products across three distinct segments – Products, Services, and Energy Production.
Curious about other stocks worth watching? Neogen, Maxeon Solar Technologies, and active queries beckon, heading into Tuesday!
Insider Trading at Silo Pharma, Inc.
- The Deal: Silo Pharma Inc. SILO CEO and President Eric Weisblum acquired 1,000 shares at an average price of $1.99, investing approximately $1,988.
- Latest News: Silo Pharma sanctioned an extension of their existing stock repurchase program, authorizing the procurement of up to $1 million in common stock until April 30.
- About Silo Pharma: Silo Pharma Inc. operates as a developmental stage biopharmaceutical firm, focusing on innovating therapeutics for overlooked conditions like stress-induced psychiatric disorders, chronic pain ailments, and central nervous system (CNS) diseases.
Don’t miss our premarket analysis for a well-rounded financial overview!
